Preview Mode Links will not work in preview mode

 

Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in digital health and the changing dynamic between doctors and patients.

Topics on the show include

  • the emergence of personalized medicine and breakthroughs in genomics
  • advances in biopharmaceuticals
  • age related diseases and aging in place
  • using big data from wearables and sensors
  • transparency in the medical marketplace
  • challenges for connected health entrepreneurs

The audience includes researchers, medical professionals, patient advocates, entrepreneurs, patients, caregivers, solution providers, students, journalists, and investors.

Sep 25, 2019

Maria Picone, Co-Founder and CEO, TREND Community was inspired to start TREND because her daughter was suffering from the rare disease Prader-Willi syndrome.  She realized there was a big gap between what doctors were telling her and what was being written about in literature and on social media.  She decided to...


Sep 25, 2019

Maria Picone, Co-Founder and CEO, TREND Community was inspired to start TREND because her daughter was suffering from the rare disease Prader-Willi syndrome.  She realized there was a big gap between what doctors were telling her and what was being written about in literature and on social media.  She decided to...


Sep 10, 2019

Nassim Usman, CEO, Catalyst Biosciences discusses the problem of Hemophilia, a rare and debilitating disease in which patients have a genetic deficiency in their ability to prevent bleeding.  Currently, these patients must receive cumbersome bi-weekly IV infusions of clotting factor replacement therapy and may still...


Sep 9, 2019

Nassim Usman, CEO, Catalyst Biosciences discusses the problem of Hemophilia, a rare disease in which patients have a genetic deficiency in their ability to prevent bleeding.  Currently, these patients must receive cumbersome bi-weekly IV infusions of clotting factor replacement therapy and may still bleed.  Catalyst...


Jul 16, 2019

Dr. Nerissa Kreher, Chief Medical Officer, Tiburio discusses the company's lead asset, TBR-760 as a novel treatment option for patients with non-functioning pituitary adenomas (NFPA), which are rare neuroendocrine tumors located in the pituitary gland.  She also speaks about the challenges facing patients even...